Inventor · disambiguated record
Mark B. Abelson
Also filed as: ABELSON MARK · ABELSON MARK B · ABELSON MARK BARRY
23 granted patents·33 pending applications·247 citations·filing 1980–2024
95Inventor score
Files withACIEX THERAPEUTICS INC9NICOX OPHTHALMICS INC7ORA INC7OPHTHALMIC RES ASSOCIATES INC4ABELSON MARK B3
Top patents by PatentIndex Score
56 records- 0190US4981871ATreatment of ocular hypertension with class I calcium channel blocking agentsABELSON MARK B·Filed 1987·Granted Jan 1, 1991·122 cites·8 claims
- 0289US10675279B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2018·Granted Jun 9, 2020·2 cites·8 claims
- 0387US8685439B2Method for the treatment and prevention of eyelid swellingCHAPIN MATTHEW JONATHAN·Filed 2007·Granted Apr 1, 2014·18 cites·3 claims
- 0485US2025108059A1Treatments of ocular allergy with alcaftadineJOHNSON & JOHNSON VISION CARE·Filed 2024·Application pending·0 cites
- 0583US9750684B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2015·Granted Sep 5, 2017·3 cites·4 claims
- 0683US8372814B2Ophthalmic formulations and uses thereofISTA PHARMACEUTICALS INC·Filed 2005·Granted Feb 12, 2013·4 cites·37 claims
- 0781US9993471B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2017·Granted Jun 12, 2018·2 cites·6 claims
- 0881US9254286B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK B·Filed 2010·Granted Feb 9, 2016·4 cites·3 claims
- 0981US2024058355A1Treatments of ocular allergy with alcaftadineJOHNSON & JOHNSON VISION CARE·Filed 2023·Application pending·0 cites
- 1079US8664215B2Ocular allergy treatments with alcaftadineINGERMAN AVNER·Filed 2007·Granted Mar 4, 2014·6 cites·11 claims
- 1178US2023181594A1Treatments of ocular allergy with alcaftadineJOHNSON & JOHNSON VISION CARE·Filed 2022·Application pending·0 cites
- 1277US11918573B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2021·Granted Mar 5, 2024·0 cites·11 claims
- 1374US11617749B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 4, 2023·0 cites·5 claims
- 1473US10987352B2Ophthalmic formulations of cetirizine and methods of useNICOX OPHTHALMICS INC·Filed 2020·Granted Apr 27, 2021·0 cites·8 claims
- 1572US10603303B2Transient receptor potential cation channel subfamily M member 8 (TRPM8) antagonists and methods of useORA INC·Filed 2017·Granted Mar 31, 2020·1 cites·22 claims
- 1670US5435998ATreatment of low-tension glaucoma by topical administration of calcium channel blocking agentsFiled 1994·Granted Jul 25, 1995·35 cites·26 claims
- 1768US2014364475A1Compositions for the treatment and prevention of eyelid swellingACIEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1868US2021177807A1Compositions for the treatment and prevention of eyelid swellingNICOX OPHTHALMICS INC·Filed 2020·Application pending·0 cites
- 1965US5431907ATreatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agentsFiled 1994·Granted Jul 11, 1995·30 cites·12 claims
- 2064US8829005B2Ophthalmic formulations of cetirizine and methods of useACIEX THERAPEUTICS INC·Filed 2013·Granted Sep 9, 2014·0 cites·8 claims
- 2164US2008261890A1Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditionsOUSLER GEORGE W·Filed 2008·Application pending·0 cites
- 2263US12048685B2Transient receptor potential cation channel subfamily m member 8 (TRPM8) antagonists and methods of useORA INC·Filed 2020·Granted Jul 30, 2024·0 cites·6 claims
- 2363US8748402B2Ophthalmic formulations and uses thereofABELSON MARK·Filed 2012·Granted Jun 10, 2014·2 cites·32 claims
- 2463US8569273B2Ophthalmic formulations of cetirizine and methods of useABELSON MARK BARRY·Filed 2010·Granted Oct 29, 2013·1 cites·14 claims
- 2563US2009136598A1Compositions for the Treatment and Prevention of Eyelid SwellingACIEX INC·Filed 2008·Application pending·0 cites
- 2663US2017079957A1Compositions for the treatment and prevention of eyelid swellingNICOX OPHTHALMICS INC·Filed 2016·Application pending·0 cites
- 2762US2021030762A1Treatments of ocular allergy with alcaftadineVISTAKON PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 2861US6465506B2Instillation techniques for ophthalmic agents to enhance treatment effectOPHTHALMIC RES ASSOCIATES INC·Filed 2002·Granted Oct 15, 2002·2 cites·8 claims
- 2961US2018140612A1Topical ophthalmic formulations for the treatment and prevention of migraine headacheORA INC·Filed 2017·Application pending·0 cites
- 3060US2010130580A1Formulations and Methods for Treating Dry EyeACIEX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3158US2017042903A1Topical Ophthalmic Formulations for the Treatment and Prevention of Migraine HeadacheORA INC·Filed 2016·Application pending·0 cites
- 3256US2009010850A1Formulations and methods for treating dry eyeOUSLER III GEORGE W·Filed 2008·Application pending·0 cites
- 3355US10617695B2Ophthalmic compositions containing alcaftadineVISTAKON PHARMACEUTICALS LLC·Filed 2016·Granted Apr 14, 2020·0 cites·20 claims
- 3453US2004198828A1Combinational use of long-acting and short-acting anti-histamines for ocular allergiesFiled 2004·Application pending·0 cites
- 3552US2012021072A1Compositions For The Treatment And Prevention Of Eyelid SwellingCHAPIN MATTHEW JONATHAN·Filed 2011·Application pending·0 cites
- 3652US2022409047A1Apparatus for capturing an image of the eyeORA INC·Filed 2022·Application pending·0 cites
- 3752US2014161903A1Compositions for the Treatment and Prevention of Eyelid SwellingACIEX THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3852US2006270592A1Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditionsOPHTHALMIC RES ASSOCIATES INC·Filed 2005·Application pending·0 cites
- 3951US11246483B2Apparatus for capturing an image of the eyeORA INC·Filed 2017·Granted Feb 15, 2022·0 cites·26 claims
- 4051US4315024ACompositions and method for treating red eyeCOOPER LAB·Filed 1980·Granted Feb 9, 1982·11 cites·3 claims
- 4150US2012027716A1Povidone Iodine, A Novel Alternative Preservative For Ophthalmic CompositionsSTEIN JASON·Filed 2009·Application pending·0 cites
- 4249US2014045803A1Ophthalmic Formulations Of Cetirizine And Methods Of UseACIEX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4347US2007254841A1Formulations and methods for treating dry eyeOPHTHALMIC RES ASSOCIATES INC·Filed 2007·Application pending·0 cites
- 4446US2013251666A1Povidone iodine, a novel alternative preservative for ophthalmic compositionsFORESIGHT BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4544US2008312194A1Methods and compositions for normalizing meibomian gland secretionsOUSLER III GEORGE W·Filed 2008·Application pending·0 cites
- 4644US2021052582A1Methods of use and pharmaceutical compositions of a selective syk inhibitorPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 4743US2005239745A1Novel topical ophthalmic formulationsOPHTHALMIC RES ASSOCIATES INC·Filed 2005·Application pending·0 cites
- 4843US2018252700A1Screening agents in dry eye diseaseABELSON MARK B·Filed 2017·Application pending·0 cites
- 4942US2008039398A1Formulations and methods for treating dry eyeOUSLER GEORGE W III·Filed 2007·Application pending·0 cites
- 5042US2007297981A1Formulations and methods for treating dry eyeOUSLER GEORGE W III·Filed 2007·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →